Summary
Client: IQVIA Solutions Canada Inc.
Project ID: P2018-030 / 2020 0970 178 000
Research Question/Objectives: This study will be conducted to better understand glycemic control in people with Type 2 diabetes (T2DM) in Canada and associated costs for the management of patients with this disease, including understanding the costs and resources for cardiovascular complications for this patient population. In addition, this project explores clinical inertia, a measure of the untimely treatment of uncontrolled diabetes.
To do so, the study will investigate the following:
- Population descriptions of a comprehensive cohort of T2DM patients using demographics, clinical characteristics, and medications.
- Prevalence and incidence of different comorbidities.
- Describe the level of glycemic control in the cohort, overall and for different lines of therapy separately.
- Describe cost per patient and the categorical and continuous relationship between glycemic control and healthcare resource utilization costs.
- Estimate the HCRU/cost per selected comorbid event.
Status: Completed
Results:
- April 2022